|
LASS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.273240E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.305360E-01 |
| Normal-vs-Stage2 |
9.947000E-01 |
| Normal-vs-Stage3 |
8.621000E-03 |
| Normal-vs-Stage4 |
4.335600E-01 |
| Stage1-vs-Stage2 |
1.718430E-01 |
| Stage1-vs-Stage3 |
9.373700E-02 |
| Stage1-vs-Stage4 |
6.804600E-01 |
| Stage2-vs-Stage3 |
3.964300E-02 |
| Stage2-vs-Stage4 |
5.085800E-01 |
| Stage3-vs-Stage4 |
1.410240E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.762000E-02 |
| Normal-vs-AfricanAmerican |
3.767800E-01 |
| Normal-vs-Asian |
5.295400E-01 |
| Caucasian-vs-AfricanAmerican |
1.404280E-02 |
| Caucasian-vs-Asian |
2.096600E-01 |
| AfricanAmerican-vs-Asian |
2.305200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.898990E-01 |
| Normal-vs-Female |
1.107570E-01 |
| Male-vs-Female |
8.683400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.169800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.485830E-01 |
| Normal-vs-Age(61-80Yrs) |
3.937200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.225700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.970400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.162000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.308200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.348800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.463200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.992350E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.082200E-02 |
| Classical-VS-Follicular |
8.423800E-01 |
| Classical-VS-Other |
8.129400E-01 |
| Classical-VS-Normal |
2.619800E-01 |
| Tall-VS-Follicular |
7.671600E-02 |
| Tall-VS-Other |
1.741850E-01 |
| Tall-VS-Normal |
8.161700E-03 |
| Follicular-VS-Other |
7.939000E-01 |
| Follicular-VS-Normal |
2.784600E-01 |
| Other-VS-Normal |
8.141200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.785180E-01 |
| Normal-vs-N1 |
6.399600E-02 |
| N0-vs-N1 |
5.098200E-01 |
|
|
